Metabasis Therapeutics Inc., of San Diego, appointed Julie Cunningham vice president of investor relations and corporate communications.
Morphotek Inc., of Exton, Pa., appointed William Claypool to its board.
Neurogen Corp., of Branford, Conn., appointed Bertrand Chenard senior vice president, chemistry and process research.
NovaDel Pharma Inc., of Flemington, N.J., appointed Thomas Bonney to its board.
Onyx Pharmaceuticals Inc., of Emeryville, Calif., appointed Thomas Wiggans to its board, which he will serve as a member of the audit committee.
Oxford BioMedica plc, of Oxford, UK, promoted Nick Woolf to its board as an executive director.
Paratek Pharmaceuticals Inc., of Boston, appointed John Dunphy vice president and chief financial officer.
PharMetrics Inc., of Watertown, Mass., appointed Stephen Boccuzzi vice president and chief scientific officer.
Predix Pharmaceuticals Inc., of Woburn, Mass., appointed Kim Drapkin chief financial officer.
Sangamo BioSciences Inc., of Richmond, Calif., appointed Margaret Liu to its board.
Savient Pharmaceuticals Inc., of East Brunswick, N.J., appointed Clifford Bacsik vice president and chief accounting officer.
Seattle Genetics Inc., of Bothell, Wash., promoted Eric Dobmeier to senior vice president, corporate development.
Solexa Inc., of Cambridge, UK, appointed Peter Lundberg vice president and chief technical officer.
SuperGen Inc., of Dublin, Calif., appointed Allan Goldberg to its board.